Is Long COVID wreaking havoc on your nervous system? In episode 110 of The One Thing Podcast, Dr. Adam Rinde interviews Dr. Robert Groysman, an anesthesiologist (MD), and pioneer in treating dysautonomia (autonomic nervous system dysfunction) and post-viral illness. Discover groundbreaking therapies, including: * **Vagal Nerve Stimulation (VNS):** Learn how affordable, transcutaneous VNS can help regulate inflammation and calm your nervous system , * **Stellate Ganglion Blocks:** Understand how this procedure, initially used for PTSD, is now offering relief from Long COVID symptoms., * **The EAT Procedure:** Discover a novel Japanese therapy (epipharyngeal abrasive therapy) targeting the root causes of inflammation, even stubborn conditions like tinnitus and Eustachian tube dysfunction. Dr. Groysman shares his unique approach to treating Long COVID, focusing on four primary causes: dysautonomia, mitochondrial dysfunction, gut dysbiosis, and mast cell activation (histamine issues). He also discusses the importance of the vagus nerve in inflammation management and why standard treatments for POTS might not be enough to address the full scope of dysautonomia. **If you're struggling with Long COVID, chronic fatigue, brain fog, or other post-viral symptoms, this episode is a must-watch!**

0:00 - Intro: Long COVID, Dysautonomia, and the Autonomic Nervous System

1:07 - Introducing Dr. Robert Groysman and His Journey

3:24 - Dr. Groysman's Medical Background and Interest in Long COVID

5:03 - Stellate Ganglion Blocks for PTSD and Connection to Long COVID

7:20 - How Dysautonomia Drives Long COVID Inflammation

9:19 - The Four Primary Causes of Long COVID11:18 - Inflammatory Mediators and Brain Fog

12:25 - Defining Dysautonomia and the Role of the Vagus Nerve

14:28 - The Vagus Nerve and Its Anti-Inflammatory Pathway

16:43 - Vagal Nerve Stimulation as a Treatment for Inflammation

17:55 - Transcutaneous Vagal Nerve Stimulation (tVNS) Devices

19:16 - Accessing the Vagus Nerve Through the Ear

21:55 - How VNS Works in the Brainstem

23:40 - Vagal Nerve Dysfunction in Long COVID

24:29 - Anesthesiology Background and VNS Therapy

26:30 - Research Supporting Vagal Nerve Stimulation

27:25 - Ear vs. Cervical Vagus Nerve Stimulation

29:30 - Choosing the TENS 7000 for tVNS

31:28 - Real-World Patient Response to tVNS

32:45 - Measuring Dysautonomia: Heart Rate Variability and Resting Heart Rate

34:15 - Orthostatic Readings and POTS

35:38 - Pre-Selecting Patients for Vagal Nerve Stimulation

36:50 - VNS as part of an Integrative Treatment Program

38:35 - Dr. Groysman's Four-Pillar Approach to Long COVID

41:10 - Long COVID Centers and Lack of Root Cause Treatments

42:48 - Introducing the EAT Procedure (Epipharyngeal Abrasive Therapy)

45:18 - How the EAT Procedure Cleans Inflamed Nasal Tissue

47:00 - Diagnosing the Need for the EAT Procedure

47:55 - EAT Procedure Success Stories: Voice Changes

49:10 - The Connection Between Vocal Cord Problems and the Vagus Nerve

50:15 - LPR (Laryngopharyngeal Reflux) and Potential Connection to Vagus Nerve

51:19 - Dr. Groysman's Practice, Telehealth and Treatment Approach

53:03 - Unique Combination of EAT and Stellate Ganglion Blocks

53:37 - Final Thoughts on Vagal Nerve Stimulation & Education

55:01 - Outro and Podcast Info

Links: Show notes: https://onethingpod.com/110-vagal-stim Dr. Groysman's facebook page https://www.facebook.com/groups/longcovidsgb Dr. Groysman's clinic https://covidinstitute.org/about-dr-groysman/ **#LongCOVID #Dysautonomia #VagalNerveStimulation #VNS #StellateGanglionBlock #EATProcedure #PostViralSyndrome #ChronicFatigue #BrainFog #Inflammation #TENS7000 #AutonomicNervousSystem #RobertGryan #DrAdamRindy #FunctionalMedicine #RootCauseTreatment**

In this Episode I welcome on Sami Inkinen CEO of Virta Health to discuss Virta Health's approach to Type 2 Diabetes reversal'

Virta Health utilizes a continuous remote care intervention (CCI) that incorporates individualized carbohydrate restriction, health coaching, and telemedicine to manage and reverse Type 2 Diabetes

We cover topics such as:

Impact of individualized carbohydrate restriction:

The role of the patient-provider relationship:

Addressing quality of food

The Virta change model:

GLP-1 Receptor agonists as a bridge:

Sustainable solutions require addressing nutrition:

Research Findings of Virta's approach.

Long-Term Effects of CCI: A 2-year non-randomized clinical trial published in Frontiers in Endocrinology showed significant and sustained improvements in multiple clinical markers of diabetes and cardiometabolic health in the CCI group compared to the UC (usual care) group . These included reductions in HbA1c, fasting glucose and insulin, weight, blood pressure, triglycerides, and liver alanine transaminase . The CCI group also saw higher rates of diabetes reversal and remission .

GLP-1 Deprescription: A recent study published in Diabetes Therapy explored the impact of discontinuing GLP-1 agonists in patients who had successfully integrated Carb-Restriction Nutrient Therapy (CRNT) supported by Virta's telemedicine model . The study found that patients did not experience weight regain after stopping GLP-1 medications, and while HbA1c levels increased slightly, they generally remained below the diagnostic threshold for diabetes

• 
  

• About Sami:

  Join NowSami InkinenFounder, Chief Executive Officer

  Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, the leader in diabetes reversal and sustainable weight loss. With a combination of proven nutrition, expert support, and advanced technology, Virta empowers members with the tools and knowledge to sustain changes for a longer, healthier life.
  

  A data-driven technology entrepreneur, Sami's personal experience with diabetes and passion to advance global health was the motivation behind Virta. Working with over 500 large employers, health plans, and government organizations across the country, Virta has helped over 100,000 members reverse their diabetes and obesity.
  

  Previously, Sami was co-founder of leading online real estate marketplace Trulia, serving as its COO, president, and board member until its IPO and eventual sale to Zillow Group, and held roles at Microsoft and McKinsey & Company. He also founded Fat Chance Row to raise awareness of the dangers of sugar and its connection to diabetes, rowing from California to Hawaii — 2,750 miles — with his wife, completely unsupported.
  

  He holds a MS in engineering physics from the Helsinki University of Technology and a MBA from Stanford University, and is also a triathlon age group world champion and 8 hour 24 minute Ironman finisher, having completed seven Hawaii Ironmans. He lives in Colorado with his wife and two daughters, enjoying the outdoors and the delight of their small barn of egg-laying chickens.

  Socials

  Website: https://www.virtahealth.com/Instagram: https://www.instagram.com/virtahealth/?hl=enFacebook: https://www.facebook.com/virtahealth/Linkedin: https://www.linkedin.com/company/virta-healthYouTube: https://www.youtube.com/virtahealthX: https://x.com/virtahealth

In this episode of The One Thing Podcast, hosted by Dr. Adam Rinde, the focus is on integrative and naturopathic medicine, specifically addressing complex chronic illnesses and cancer care. Dr. Rinde introduces the guest, Dr. Paul Anderson, a leading voice in the field with over 30 years of clinical experience. The episode aims to explore the topic of coagulopathy in chronic disease, discussing its mechanisms, implications, and potential treatments.

Guest Highlights • Dr. Paul Anderson: o Leading voice in integrative and naturopathic medicine. o Specializes in complex chronic illness and cancer care. o Over 30 years of clinical experience. o Led the interventional arm of a US NIH-funded human research trial on IV and integrative therapies for cancer patients. o Founder of Advanced Medical Therapies in Seattle, Washington. o Collaborates with clinics and hospitals worldwide. o Academic contributions include serving as a professor of pharmacology and clinical medicine and as the chief of IV Services for Baer's Oncology Research Center. o Published works include "Outside the Box Cancer Therapies" and "Cancer, the Journey for Diagnosis to Empowerment." o Notable work on intravenous nutrient therapy featured in a scientific reference textbook. Main Topics Covered 1. Mechanisms of Coagulation: o Discussion on the intrinsic and extrinsic pathways of coagulation. o Role of immune chemicals in triggering clotting. o Impact of chronic illnesses and infections like COVID-19 on coagulation. 2. Coagulopathy in Chronic Disease: o Excessive coagulation in chronic disease states. o Specific conditions discussed include COVID-19, fibromyalgia, chronic fatigue syndrome, and POTS (postural orthostatic tachycardia syndrome). o How coagulopathies may hinder patient recovery and the importance of assessing and addressing these issues. 3. Genetic and Environmental Factors: o Influence of genetics on susceptibility to hypercoagulability. o Role of diet, hydration, and lifestyle in managing coagulation issues. o Importance of testing and early detection for prevention and treatment. 4. Treatment Approaches: o Use of supplements like vitamin E, omega oils, and fibrinolytic enzymes (e.g., nattokinase, lumbrokinase). o Potential use of baby aspirin for managing clotting issues. o Importance of a stepwise approach to treatment, starting with lifestyle modifications and progressing to more intensive interventions if necessary. 5. Biofilm and Chronic Infections: o Connection between biofilm formation and chronic infections. o How pathogens use fibrin to form protective biofilms, complicating treatment. o Strategies for breaking down biofilms to improve patient outcomes. 6. Hope and Recovery: o Emphasis on the possibility of recovery from chronic illnesses and coagulopathies. o Importance of finding a supportive healthcare team and utilizing available resources for treatment and management

Related Links 1. Dr. Paul Anderson's Books: o "Outside the Box Cancer Therapies" by Dr. Paul Anderson and Dr. Mark Stengler o "Cancer, the Journey from Diagnosis to Empowerment" by Dr. Paul Anderson 2. Research on Coagulation and COVID-19: o Studies on interleukin-6 and its role in COVID-19 o Research on microclots in COVID-19 patients 3. Supplements Mentioned: o Nattokinase o Lumbrokinase o Baby aspirin o Vitamin E o Omega oils 4. Organizations and Labs: o Fry Laboratories (historical reference) 5. Conditions Discussed: o COVID-19 and Long COVID

Socials Mentioned: